NuGene announced that it has appointed Ted Schwarz to their Board of Directors, effective June 13, 2016. Mr. Schwarz previously served as President of SkinMedica. Mr. Schwarz most recently served as President of Sienna Labs where he co-developed the business plan to bring to market topical solutions based on plasmonic resonance for treatment of both aesthetic and disease based dermatological indications.